NCT03312088View on ClinicalTrials.gov

Maxx Orthopedics' PCK Revision TKA Study of Component Survivorship

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 1, 2022

Study Completion Date

February 28, 2022

Conditions
Aseptic LooseningInfectionBone LossMCL - Medial Collateral Ligament Rupture of the KneePeriprosthetic Fractures
Interventions
DEVICE

Freedom Knee PCK Components

Total Knee Revision

Trial Locations (1)

34209

RECRUITING

Coastal Orthopedics, Bradenton

Sponsors
All Listed Sponsors
lead

Maxx Orthopedics Inc

INDUSTRY